Related references
Note: Only part of the references are listed.An Improved Approach To Measuring Drug Innovation Finds Steady Rates Of First-In-Class Pharmaceuticals, 1987-2011
Michael Lanthier et al.
HEALTH AFFAIRS (2013)
Engineered in India Patent Law 2.0
Amy Kapczynski
NEW ENGLAND JOURNAL OF MEDICINE (2013)
INVESTMENTS IN PHARMACEUTICALS BEFORE AND AFTER TRIPS
Margaret K. Kyle et al.
REVIEW OF ECONOMICS AND STATISTICS (2012)
Economic Perspectives On The Advance Market Commitment For Pneumococcal Vaccines
Christopher M. Snyder et al.
HEALTH AFFAIRS (2011)
Diffusion of New Drugs in the Post-TRIPS Era
Ernst Berndt et al.
INTERNATIONAL JOURNAL OF THE ECONOMICS OF BUSINESS (2011)
International prices and availability of pharmaceuticals in 2005
Patricia M. Danzon et al.
HEALTH AFFAIRS (2008)
Pharmaceutical price controls and entry strategies
Margaret K. Kyle
REVIEW OF ECONOMICS AND STATISTICS (2007)
Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India
Shubham Chaudhuri et al.
AMERICAN ECONOMIC REVIEW (2006)
Developing drugs for developing countries
DB Ridley et al.
HEALTH AFFAIRS (2006)
Post-TRIPS options for access to patented medicines in developing nations
FM Scherer et al.
JOURNAL OF INTERNATIONAL ECONOMIC LAW (2002)
Share Paper
